# Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT02269150** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 59 (actual)

## Conditions studied

- Allogeneic Hematopoietic Stem Cell

## Interventions

- **BIOLOGICAL:** fecal microbiota transplantation (FMT)
- **OTHER:** No fecal microbiota transplantation (FMT), routine management

## Key facts

- **NCT ID:** NCT02269150
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-10
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02269150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02269150, "Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02269150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*